Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 47 entries
Sorted by: Best Match Show Resources per page
Unknown Use of End-tidal CO.

Journal of translational internal medicine

Redant S, Angoulvant F, Honore PM, Attou R, Biarent D, De Bels D.
PMID: 31380240
J Transl Int Med. 2019 Jul 11;7(2):76-78. doi: 10.2478/jtim-2019-0015. eCollection 2019 Jun.

The authors describe two cases of metabolic acidosis, caused by diabetic ketoacidosis in the first case and by dehydration following gastroenteritis in the second one. Both patients were followed with noninvasive end-tidal CO

Cite
Redant S, Angoulvant F, Honore PM, et al. Unknown Use of End-tidal CO. J Transl Int Med. 2019;7(2):76-78doi: 10.2478/jtim-2019-0015.
Redant, S., Angoulvant, F., Honore, P. M., Attou, R., Biarent, D., & De Bels, D. (2019). Unknown Use of End-tidal CO. Journal of translational internal medicine, 7(2), 76-78. https://doi.org/10.2478/jtim-2019-0015
Redant, Sebastien, et al. "Unknown Use of End-tidal CO." Journal of translational internal medicine vol. 7,2 (2019): 76-78. doi: https://doi.org/10.2478/jtim-2019-0015
Redant S, Angoulvant F, Honore PM, Attou R, Biarent D, De Bels D. Unknown Use of End-tidal CO. J Transl Int Med. 2019 Jul 11;7(2):76-78. doi: 10.2478/jtim-2019-0015. eCollection 2019 Jun. PMID: 31380240; PMCID: PMC6661873.
Copy Download .nbib Format: NLM
Regadenoson versus dipyridamole: Evaluation of stress myocardial blood flow response on a CZT-SPECT camera.

Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology

Brana Q, Thibault F, Courtehoux M, Metrard G, Ribeiro MJ, Angoulvant D, Bailly M.
PMID: 32651801
J Nucl Cardiol. 2020 Jul 10; doi: 10.1007/s12350-020-02271-5. Epub 2020 Jul 10.

BACKGROUND: Regadenoson is a selective adenosine receptor agonist. It is currently unclear if the level of hyperemia differs between stress agents. We compared Myocardial Blood Flow (MBF) and Myocardial Flow Reserve (MFR) response on CZT-SPECT Myocardial Perfusion Imaging (MPI)...

Cite
Brana Q, Thibault F, Courtehoux M, et al. Regadenoson versus dipyridamole: Evaluation of stress myocardial blood flow response on a CZT-SPECT camera. J Nucl Cardiol. 2020;doi: 10.1007/s12350-020-02271-5.
Brana, Q., Thibault, F., Courtehoux, M., Metrard, G., Ribeiro, M. J., Angoulvant, D., & Bailly, M. (2020). Regadenoson versus dipyridamole: Evaluation of stress myocardial blood flow response on a CZT-SPECT camera. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, . https://doi.org/10.1007/s12350-020-02271-5
Brana, Quentin, et al. "Regadenoson versus dipyridamole: Evaluation of stress myocardial blood flow response on a CZT-SPECT camera." Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology vol. (2020). doi: https://doi.org/10.1007/s12350-020-02271-5
Brana Q, Thibault F, Courtehoux M, Metrard G, Ribeiro MJ, Angoulvant D, Bailly M. Regadenoson versus dipyridamole: Evaluation of stress myocardial blood flow response on a CZT-SPECT camera. J Nucl Cardiol. 2020 Jul 10; doi: 10.1007/s12350-020-02271-5. Epub 2020 Jul 10. PMID: 32651801.
Copy Download .nbib Format: NLM
Specific impact of past and new major cardiovascular events on acute kidney injury and end-stage renal disease risks in diabetes: a dynamic view.

Clinical kidney journal

Pinier C, Gatault P, Fauchier L, Angoulvant D, François M, Barbet C, Bailly E, Noble J, Chevallier E, Rabot N, Büchler M, Sautenet B, Halimi JM.
PMID: 32083616
Clin Kidney J. 2019 Apr 16;13(1):17-23. doi: 10.1093/ckj/sfz028. eCollection 2020 Feb.

BACKGROUND: Interconnections between major cardiovascular events (MCVEs) and renal events are recognized in diabetes, however, the specific impact of atrial fibrillation (AF), heart failure (HF) and acute coronary syndrome (ACS) on the risk of end-stage renal disease (ESRD) on...

Cite
Pinier C, Gatault P, Fauchier L, et al. Specific impact of past and new major cardiovascular events on acute kidney injury and end-stage renal disease risks in diabetes: a dynamic view. Clin Kidney J. 2019;13(1):17-23doi: 10.1093/ckj/sfz028.
Pinier, C., Gatault, P., Fauchier, L., Angoulvant, D., François, M., Barbet, C., Bailly, E., Noble, J., Chevallier, E., Rabot, N., Büchler, M., Sautenet, B., & Halimi, J. M. (2020). Specific impact of past and new major cardiovascular events on acute kidney injury and end-stage renal disease risks in diabetes: a dynamic view. Clinical kidney journal, 13(1), 17-23. https://doi.org/10.1093/ckj/sfz028
Pinier, Cédric, et al. "Specific impact of past and new major cardiovascular events on acute kidney injury and end-stage renal disease risks in diabetes: a dynamic view." Clinical kidney journal vol. 13,1 (2020): 17-23. doi: https://doi.org/10.1093/ckj/sfz028
Pinier C, Gatault P, Fauchier L, Angoulvant D, François M, Barbet C, Bailly E, Noble J, Chevallier E, Rabot N, Büchler M, Sautenet B, Halimi JM. Specific impact of past and new major cardiovascular events on acute kidney injury and end-stage renal disease risks in diabetes: a dynamic view. Clin Kidney J. 2019 Apr 16;13(1):17-23. doi: 10.1093/ckj/sfz028. eCollection 2020 Feb. PMID: 32083616; PMCID: PMC7025370.
Copy Download .nbib Format: NLM
Educational Setting and SARS-CoV-2 Transmission Among Children With Multisystem Inflammatory Syndrome: A French National Surveillance System.

Frontiers in pediatrics

Guenver C, Oualha M, Levy C, Antona D, Madhi F, Toubiana J, Lachaume N, Javouhey E, Lorrot M, Yang DD, Levy M, Caseris M, Galeotti C, Ovaert C, Wiedemann A, Girardin ML, Rybak A, Cohen R, Belot A, Angoulvant F, Ouldali N.
PMID: 34765576
Front Pediatr. 2021 Oct 26;9:745364. doi: 10.3389/fped.2021.745364. eCollection 2021.

No abstract available.

Cite
Guenver C, Oualha M, Levy C, et al. Educational Setting and SARS-CoV-2 Transmission Among Children With Multisystem Inflammatory Syndrome: A French National Surveillance System. Front Pediatr. 2021;9:745364doi: 10.3389/fped.2021.745364.
Guenver, C., Oualha, M., Levy, C., Antona, D., Madhi, F., Toubiana, J., Lachaume, N., Javouhey, E., Lorrot, M., Yang, D. D., Levy, M., Caseris, M., Galeotti, C., Ovaert, C., Wiedemann, A., Girardin, M. L., Rybak, A., Cohen, R., Belot, A., Angoulvant, F., & Ouldali, N. (2021). Educational Setting and SARS-CoV-2 Transmission Among Children With Multisystem Inflammatory Syndrome: A French National Surveillance System. Frontiers in pediatrics, 9745364. https://doi.org/10.3389/fped.2021.745364
Guenver, Celia, et al. "Educational Setting and SARS-CoV-2 Transmission Among Children With Multisystem Inflammatory Syndrome: A French National Surveillance System." Frontiers in pediatrics vol. 9 (2021): 745364. doi: https://doi.org/10.3389/fped.2021.745364
Guenver C, Oualha M, Levy C, Antona D, Madhi F, Toubiana J, Lachaume N, Javouhey E, Lorrot M, Yang DD, Levy M, Caseris M, Galeotti C, Ovaert C, Wiedemann A, Girardin ML, Rybak A, Cohen R, Belot A, Angoulvant F, Ouldali N. Educational Setting and SARS-CoV-2 Transmission Among Children With Multisystem Inflammatory Syndrome: A French National Surveillance System. Front Pediatr. 2021 Oct 26;9:745364. doi: 10.3389/fped.2021.745364. eCollection 2021. PMID: 34765576; PMCID: PMC8576449.
Copy Download .nbib Format: NLM
Impact of the French National Lockdown on Admissions to 14 Pediatric Intensive Care Units During the 2020 COVID-19 Pandemic-A Retrospective Multicenter Study.

Frontiers in pediatrics

Breinig S, Mortamet G, Brossier D, Amadieu R, Claudet I, Javouhey E, Angoulvant F, Arnaud C.
PMID: 34956977
Front Pediatr. 2021 Dec 10;9:764583. doi: 10.3389/fped.2021.764583. eCollection 2021.

No abstract available.

Cite
Breinig S, Mortamet G, Brossier D, et al. Impact of the French National Lockdown on Admissions to 14 Pediatric Intensive Care Units During the 2020 COVID-19 Pandemic-A Retrospective Multicenter Study. Front Pediatr. 2021;9:764583doi: 10.3389/fped.2021.764583.
Breinig, S., Mortamet, G., Brossier, D., Amadieu, R., Claudet, I., Javouhey, E., Angoulvant, F., & Arnaud, C. (2021). Impact of the French National Lockdown on Admissions to 14 Pediatric Intensive Care Units During the 2020 COVID-19 Pandemic-A Retrospective Multicenter Study. Frontiers in pediatrics, 9764583. https://doi.org/10.3389/fped.2021.764583
Breinig, Sophie, et al. "Impact of the French National Lockdown on Admissions to 14 Pediatric Intensive Care Units During the 2020 COVID-19 Pandemic-A Retrospective Multicenter Study." Frontiers in pediatrics vol. 9 (2021): 764583. doi: https://doi.org/10.3389/fped.2021.764583
Breinig S, Mortamet G, Brossier D, Amadieu R, Claudet I, Javouhey E, Angoulvant F, Arnaud C. Impact of the French National Lockdown on Admissions to 14 Pediatric Intensive Care Units During the 2020 COVID-19 Pandemic-A Retrospective Multicenter Study. Front Pediatr. 2021 Dec 10;9:764583. doi: 10.3389/fped.2021.764583. eCollection 2021. PMID: 34956977; PMCID: PMC8709570.
Copy Download .nbib Format: NLM
Effect of Colchicine on Myocardial Injury in Acute Myocardial Infarction.

Circulation

Mewton N, Roubille F, Bresson D, Prieur C, Bouleti C, Bochaton T, Ivanes F, Dubreuil O, Biere L, Hayek A, Derimay F, Akodad M, Alos B, Haider L, El Jonhy N, Daw R, De Bourguignon C, Dhelens C, Finet G, Bonnefoy-Cudraz E, Bidaux G, Boutitie F, Maucort-Boulch D, Croisille P, Rioufol G, Prunier F, Angoulvant D.
PMID: 34420373
Circulation. 2021 Sep 14;144(11):859-869. doi: 10.1161/CIRCULATIONAHA.121.056177. Epub 2021 Aug 23.

BACKGROUND: Inflammation is a key factor of myocardial damage in reperfused ST-segment-elevation myocardial infarction. We hypothesized that colchicine, a potent anti-inflammatory agent, may reduce infarct size (IS) and left ventricular (LV) remodeling at the acute phase of ST-segment-elevation myocardial...

Cite
Mewton N, Roubille F, Bresson D, et al. Effect of Colchicine on Myocardial Injury in Acute Myocardial Infarction. Circulation. 2021;144(11):859-869doi: 10.1161/CIRCULATIONAHA.121.056177.
Mewton, N., Roubille, F., Bresson, D., Prieur, C., Bouleti, C., Bochaton, T., Ivanes, F., Dubreuil, O., Biere, L., Hayek, A., Derimay, F., Akodad, M., Alos, B., Haider, L., El Jonhy, N., Daw, R., De Bourguignon, C., Dhelens, C., Finet, G., Bonnefoy-Cudraz, E., Bidaux, G., Boutitie, F., Maucort-Boulch, D., Croisille, P., Rioufol, G., Prunier, F., & Angoulvant, D. (2021). Effect of Colchicine on Myocardial Injury in Acute Myocardial Infarction. Circulation, 144(11), 859-869. https://doi.org/10.1161/CIRCULATIONAHA.121.056177
Mewton, Nathan, et al. "Effect of Colchicine on Myocardial Injury in Acute Myocardial Infarction." Circulation vol. 144,11 (2021): 859-869. doi: https://doi.org/10.1161/CIRCULATIONAHA.121.056177
Mewton N, Roubille F, Bresson D, Prieur C, Bouleti C, Bochaton T, Ivanes F, Dubreuil O, Biere L, Hayek A, Derimay F, Akodad M, Alos B, Haider L, El Jonhy N, Daw R, De Bourguignon C, Dhelens C, Finet G, Bonnefoy-Cudraz E, Bidaux G, Boutitie F, Maucort-Boulch D, Croisille P, Rioufol G, Prunier F, Angoulvant D. Effect of Colchicine on Myocardial Injury in Acute Myocardial Infarction. Circulation. 2021 Sep 14;144(11):859-869. doi: 10.1161/CIRCULATIONAHA.121.056177. Epub 2021 Aug 23. PMID: 34420373; PMCID: PMC8462445.
Copy Download .nbib Format: NLM
NSTE-ACS ESC Guidelines Recommend Prasugrel as the Preferred P2Y12 Inhibitor: A Contrarian View.

American journal of cardiovascular drugs : drugs, devices, and other interventions

Angoulvant D, Sabouret P, Savage MP.
PMID: 33674980
Am J Cardiovasc Drugs. 2021 Sep;21(5):483-486. doi: 10.1007/s40256-021-00471-z. Epub 2021 Mar 06.

In the 2020 European Society of Cardiology guidelines on non-ST-segment elevation acute coronary syndromes (NSTE-ACS), the experts proposed to put an end to the equipoise of ticagrelor and prasugrel in addition to aspirin in patients with NSTE-ACS who proceed...

Cite
Angoulvant D, Sabouret P, Savage MP. NSTE-ACS ESC Guidelines Recommend Prasugrel as the Preferred P2Y12 Inhibitor: A Contrarian View. Am J Cardiovasc Drugs. 2021;21(5):483-486doi: 10.1007/s40256-021-00471-z.
Angoulvant, D., Sabouret, P., & Savage, M. P. (2021). NSTE-ACS ESC Guidelines Recommend Prasugrel as the Preferred P2Y12 Inhibitor: A Contrarian View. American journal of cardiovascular drugs : drugs, devices, and other interventions, 21(5), 483-486. https://doi.org/10.1007/s40256-021-00471-z
Angoulvant, Denis, et al. "NSTE-ACS ESC Guidelines Recommend Prasugrel as the Preferred P2Y12 Inhibitor: A Contrarian View." American journal of cardiovascular drugs : drugs, devices, and other interventions vol. 21,5 (2021): 483-486. doi: https://doi.org/10.1007/s40256-021-00471-z
Angoulvant D, Sabouret P, Savage MP. NSTE-ACS ESC Guidelines Recommend Prasugrel as the Preferred P2Y12 Inhibitor: A Contrarian View. Am J Cardiovasc Drugs. 2021 Sep;21(5):483-486. doi: 10.1007/s40256-021-00471-z. Epub 2021 Mar 06. PMID: 33674980; PMCID: PMC8435520.
Copy Download .nbib Format: NLM
Myocardial Flow Reserve Measurement During CZT-SPECT Perfusion Imaging for Coronary Artery Disease Screening: Correlation With Clinical Findings and Invasive Coronary Angiography-The CFR-OR Study.

Frontiers in medicine

Bailly M, Thibault F, Courtehoux M, Metrard G, Angoulvant D, Ribeiro MJ.
PMID: 34150820
Front Med (Lausanne). 2021 Jun 04;8:691893. doi: 10.3389/fmed.2021.691893. eCollection 2021.

No abstract available.

Cite
Bailly M, Thibault F, Courtehoux M, et al. Myocardial Flow Reserve Measurement During CZT-SPECT Perfusion Imaging for Coronary Artery Disease Screening: Correlation With Clinical Findings and Invasive Coronary Angiography-The CFR-OR Study. Front Med (Lausanne). 2021;8:691893doi: 10.3389/fmed.2021.691893.
Bailly, M., Thibault, F., Courtehoux, M., Metrard, G., Angoulvant, D., & Ribeiro, M. J. (2021). Myocardial Flow Reserve Measurement During CZT-SPECT Perfusion Imaging for Coronary Artery Disease Screening: Correlation With Clinical Findings and Invasive Coronary Angiography-The CFR-OR Study. Frontiers in medicine, 8691893. https://doi.org/10.3389/fmed.2021.691893
Bailly, Matthieu, et al. "Myocardial Flow Reserve Measurement During CZT-SPECT Perfusion Imaging for Coronary Artery Disease Screening: Correlation With Clinical Findings and Invasive Coronary Angiography-The CFR-OR Study." Frontiers in medicine vol. 8 (2021): 691893. doi: https://doi.org/10.3389/fmed.2021.691893
Bailly M, Thibault F, Courtehoux M, Metrard G, Angoulvant D, Ribeiro MJ. Myocardial Flow Reserve Measurement During CZT-SPECT Perfusion Imaging for Coronary Artery Disease Screening: Correlation With Clinical Findings and Invasive Coronary Angiography-The CFR-OR Study. Front Med (Lausanne). 2021 Jun 04;8:691893. doi: 10.3389/fmed.2021.691893. eCollection 2021. PMID: 34150820; PMCID: PMC8212953.
Copy Download .nbib Format: NLM
Glucose-lowering drug use and new-onset atrial fibrillation in patients with diabetes mellitus.

Diabetologia

Fauchier G, Bisson A, Bodin A, Herbert J, Angoulvant D, Ducluzeau PH, Lip GYH, Fauchier L.
PMID: 34435218
Diabetologia. 2021 Nov;64(11):2602-2605. doi: 10.1007/s00125-021-05551-y. Epub 2021 Aug 25.

No abstract available.

Cite
Fauchier G, Bisson A, Bodin A, et al. Glucose-lowering drug use and new-onset atrial fibrillation in patients with diabetes mellitus. Diabetologia. 2021;64(11):2602-2605doi: 10.1007/s00125-021-05551-y.
Fauchier, G., Bisson, A., Bodin, A., Herbert, J., Angoulvant, D., Ducluzeau, P. H., Lip, G. Y. H., & Fauchier, L. (2021). Glucose-lowering drug use and new-onset atrial fibrillation in patients with diabetes mellitus. Diabetologia, 64(11), 2602-2605. https://doi.org/10.1007/s00125-021-05551-y
Fauchier, Gregoire, et al. "Glucose-lowering drug use and new-onset atrial fibrillation in patients with diabetes mellitus." Diabetologia vol. 64,11 (2021): 2602-2605. doi: https://doi.org/10.1007/s00125-021-05551-y
Fauchier G, Bisson A, Bodin A, Herbert J, Angoulvant D, Ducluzeau PH, Lip GYH, Fauchier L. Glucose-lowering drug use and new-onset atrial fibrillation in patients with diabetes mellitus. Diabetologia. 2021 Nov;64(11):2602-2605. doi: 10.1007/s00125-021-05551-y. Epub 2021 Aug 25. PMID: 34435218.
Copy Download .nbib Format: NLM
Association Between Mortality and Anti-Vascular Endothelial Growth Factor Treatment in Patients With Age-Related Macular Degeneration-Reply.

JAMA ophthalmology

Ngo Ntjam N, Angoulvant D, Bejan-Angoulvant T.
PMID: 34647976
JAMA Ophthalmol. 2021 Nov 01;139(11):1247-1248. doi: 10.1001/jamaophthalmol.2021.4082.

No abstract available.

Cite
Ngo Ntjam N, Angoulvant D, Bejan-Angoulvant T. Association Between Mortality and Anti-Vascular Endothelial Growth Factor Treatment in Patients With Age-Related Macular Degeneration-Reply. JAMA Ophthalmol. 2021;139(11):1247-1248doi: 10.1001/jamaophthalmol.2021.4082.
Ngo Ntjam, N., Angoulvant, D., & Bejan-Angoulvant, T. (2021). Association Between Mortality and Anti-Vascular Endothelial Growth Factor Treatment in Patients With Age-Related Macular Degeneration-Reply. JAMA ophthalmology, 139(11), 1247-1248. https://doi.org/10.1001/jamaophthalmol.2021.4082
Ngo Ntjam, Nadège, et al. "Association Between Mortality and Anti-Vascular Endothelial Growth Factor Treatment in Patients With Age-Related Macular Degeneration-Reply." JAMA ophthalmology vol. 139,11 (2021): 1247-1248. doi: https://doi.org/10.1001/jamaophthalmol.2021.4082
Ngo Ntjam N, Angoulvant D, Bejan-Angoulvant T. Association Between Mortality and Anti-Vascular Endothelial Growth Factor Treatment in Patients With Age-Related Macular Degeneration-Reply. JAMA Ophthalmol. 2021 Nov 01;139(11):1247-1248. doi: 10.1001/jamaophthalmol.2021.4082. PMID: 34647976.
Copy Download .nbib Format: NLM
Impact of gender on relative rates of cardiovascular events in patients with diabetes.

Diabetes & metabolism

Angoulvant D, Ducluzeau PH, Renoult-Pierre P, Fauchier G, Herbert J, Semaan C, Bodin A, Bisson A, Fauchier L.
PMID: 33454437
Diabetes Metab. 2021 Sep;47(5):101226. doi: 10.1016/j.diabet.2021.101226. Epub 2021 Jan 14.

AIM: To investigate whether diabetes confers higher relative risks of cardiovascular events in women compared with men using contemporary data and also whether such gender-differences are dependent on age.METHODS: All patients discharged from French hospitals in 2013 with at...

Cite
Angoulvant D, Ducluzeau PH, Renoult-Pierre P, et al. Impact of gender on relative rates of cardiovascular events in patients with diabetes. Diabetes Metab. 2021;47(5):101226doi: 10.1016/j.diabet.2021.101226.
Angoulvant, D., Ducluzeau, P. H., Renoult-Pierre, P., Fauchier, G., Herbert, J., Semaan, C., Bodin, A., Bisson, A., & Fauchier, L. (2021). Impact of gender on relative rates of cardiovascular events in patients with diabetes. Diabetes & metabolism, 47(5), 101226. https://doi.org/10.1016/j.diabet.2021.101226
Angoulvant, Denis, et al. "Impact of gender on relative rates of cardiovascular events in patients with diabetes." Diabetes & metabolism vol. 47,5 (2021): 101226. doi: https://doi.org/10.1016/j.diabet.2021.101226
Angoulvant D, Ducluzeau PH, Renoult-Pierre P, Fauchier G, Herbert J, Semaan C, Bodin A, Bisson A, Fauchier L. Impact of gender on relative rates of cardiovascular events in patients with diabetes. Diabetes Metab. 2021 Sep;47(5):101226. doi: 10.1016/j.diabet.2021.101226. Epub 2021 Jan 14. PMID: 33454437.
Copy Download .nbib Format: NLM
Combining flow and reserve measurement during myocardial perfusion imaging: A new era for myocardial perfusion scintigraphy?.

Archives of cardiovascular diseases

Bailly M, Ribeiro MJ, Angoulvant D.
PMID: 34801410
Arch Cardiovasc Dis. 2021 Dec;114(12):818-827. doi: 10.1016/j.acvd.2021.10.006. Epub 2021 Nov 17.

Myocardial flow reserve represents the ratio of myocardial blood flow between stress and rest, giving functional information about both macrocirculation and microcirculation; it has been reported extensively in positron emission tomography, with an increase in diagnostic performance, providing important...

Cite
Bailly M, Ribeiro MJ, Angoulvant D. Combining flow and reserve measurement during myocardial perfusion imaging: A new era for myocardial perfusion scintigraphy?. Arch Cardiovasc Dis. 2021;114(12):818-827doi: 10.1016/j.acvd.2021.10.006.
Bailly, M., Ribeiro, M. J., & Angoulvant, D. (2021). Combining flow and reserve measurement during myocardial perfusion imaging: A new era for myocardial perfusion scintigraphy?. Archives of cardiovascular diseases, 114(12), 818-827. https://doi.org/10.1016/j.acvd.2021.10.006
Bailly, Matthieu, et al. "Combining flow and reserve measurement during myocardial perfusion imaging: A new era for myocardial perfusion scintigraphy?." Archives of cardiovascular diseases vol. 114,12 (2021): 818-827. doi: https://doi.org/10.1016/j.acvd.2021.10.006
Bailly M, Ribeiro MJ, Angoulvant D. Combining flow and reserve measurement during myocardial perfusion imaging: A new era for myocardial perfusion scintigraphy?. Arch Cardiovasc Dis. 2021 Dec;114(12):818-827. doi: 10.1016/j.acvd.2021.10.006. Epub 2021 Nov 17. PMID: 34801410.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 47 entries